Figures & data
Table 1. Basic characteristics of included literature.
Figure 3. Forest plots for the Comparisons of clinical indicators between two groups of patients with PCOS (A: systolic blood pressure, SBP; B: diastolic blood pressure, DBP; C: glucose; D: sex hormone-binding globulin, SHBG).
![Figure 3. Forest plots for the Comparisons of clinical indicators between two groups of patients with PCOS (A: systolic blood pressure, SBP; B: diastolic blood pressure, DBP; C: glucose; D: sex hormone-binding globulin, SHBG).](/cms/asset/421d4450-e5d9-4c41-bb1f-789b4b75f9e0/igye_a_2239934_f0003_b.jpg)
Figure 4. Sensitivity analysis of clinical indicators in two groups of patients with PCOS (A: systolic blood pressure, SBP; B: diastolic blood pressure, DBP; C: glucose; D: sex hormone-binding globulin, SHBG).
![Figure 4. Sensitivity analysis of clinical indicators in two groups of patients with PCOS (A: systolic blood pressure, SBP; B: diastolic blood pressure, DBP; C: glucose; D: sex hormone-binding globulin, SHBG).](/cms/asset/200336c2-94de-4998-9470-e7c848b25aa9/igye_a_2239934_f0004_b.jpg)
Figure 5. Funnel plots of clinical indicators in two groups of patients with PCOS (A: systolic blood pressure, SBP; B: diastolic blood pressure, DBP; C: glucose; D: sex hormone-binding globulin, SHBG).
![Figure 5. Funnel plots of clinical indicators in two groups of patients with PCOS (A: systolic blood pressure, SBP; B: diastolic blood pressure, DBP; C: glucose; D: sex hormone-binding globulin, SHBG).](/cms/asset/b97619d4-3d16-4a66-b0d7-6591ae036f77/igye_a_2239934_f0005_b.jpg)
Figure 6. Forest plots for the comparison of blood lipid parameters between two groups of patients with PCOS (A: total cholesterol, TC; B: triglyceride, TG; C: low-density lipoprotein, LDL; D: high-density lipoprotein, HDL).
![Figure 6. Forest plots for the comparison of blood lipid parameters between two groups of patients with PCOS (A: total cholesterol, TC; B: triglyceride, TG; C: low-density lipoprotein, LDL; D: high-density lipoprotein, HDL).](/cms/asset/23d270cd-45e9-49c5-acb4-0afc768742e2/igye_a_2239934_f0006_b.jpg)
Figure 7. Sensitivity analysis of blood lipid parameters in two groups of patients with PCOS (A: total cholesterol, TC; B: triglyceride, TG; C: low-density lipoprotein, LDL; D: high-density lipoprotein, HDL).
![Figure 7. Sensitivity analysis of blood lipid parameters in two groups of patients with PCOS (A: total cholesterol, TC; B: triglyceride, TG; C: low-density lipoprotein, LDL; D: high-density lipoprotein, HDL).](/cms/asset/82e0becf-d73e-4e04-9357-f8de36f1e008/igye_a_2239934_f0007_b.jpg)
Figure 8. Funnel plots of blood lipid parameters in two groups of patients with PCOS (A: total cholesterol, TC; B: triglyceride, TG; C: low-density lipoprotein, LDL; D: high-density lipoprotein, HDL).
![Figure 8. Funnel plots of blood lipid parameters in two groups of patients with PCOS (A: total cholesterol, TC; B: triglyceride, TG; C: low-density lipoprotein, LDL; D: high-density lipoprotein, HDL).](/cms/asset/b2c67c70-16db-49c1-9582-9f45072a629e/igye_a_2239934_f0008_b.jpg)
Figure 9. Meta-analysis of hormone indicators in two groups of patients with PCOS.
C: Forest plots of luteinizing hormone (LH, A), follicle stimulating hormone (FSH, B), testosterone (C); D-F: Sensitivity analysis of LH (D), FSH (E), testosterone (F); G-I: Funnel plots of LH (G), FSH (H), testosterone (I)
![Figure 9. Meta-analysis of hormone indicators in two groups of patients with PCOS.C: Forest plots of luteinizing hormone (LH, A), follicle stimulating hormone (FSH, B), testosterone (C); D-F: Sensitivity analysis of LH (D), FSH (E), testosterone (F); G-I: Funnel plots of LH (G), FSH (H), testosterone (I)](/cms/asset/8c9bc522-da75-46bc-be2a-d997c7b62b22/igye_a_2239934_f0009_b.jpg)
Supplemental Material
Download MS Word (12.1 KB)Availability of data and materials
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.